tiprankstipranks
Trending News
More News >
Kuros Biosciences (CSBTF)
:CSBTF
US Market

Kuros Biosciences (CSBTF) Income Statement

Compare
13 Followers

Kuros Biosciences Income Statement

Last quarter (Q2 2024), Kuros Biosciences's total revenue was CHF31.84M, an increase of 205.43% from the same quarter last year. In Q2, Kuros Biosciences's net income was CHF-211.00K. See Kuros Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
CHF 75.56MCHF 33.56MCHF 17.99MCHF 13.81MCHF 4.04M
Gross Profit
CHF 62.03MCHF 23.94MCHF 10.77MCHF 10.07MCHF 1.67M
Operating Expenses
CHF 67.03MCHF 37.13MCHF 24.21MCHF 18.83MCHF 13.35M
Depreciation and Amortization
CHF 2.64MCHF 2.75MCHF 2.83MCHF 2.88MCHF 2.67M
EBITDA
CHF -561.00KCHF -6.84MCHF -8.84MCHF -5.29MCHF -8.58M
Operating Income
CHF -5.00MCHF -13.19MCHF -13.45MCHF -8.77MCHF -11.68M
Other Income/Expenses
CHF 1.65MCHF -155.00KCHF -2.54MCHF -787.00KCHF -415.00K
Pretax Income
CHF -3.35MCHF -13.35MCHF -15.99MCHF -9.55MCHF -12.09M
Net Income
CHF -3.72MCHF -13.73MCHF -14.60MCHF -7.54MCHF -11.52M
Per Share Metrics
Basic EPS
CHF -0.10CHF -0.38CHF -0.43CHF -0.23CHF -0.47
Diluted EPS
CHF -0.10CHF -0.38CHF -0.43CHF -0.23CHF -0.47
Weighted Average Shares Outstanding
37.20M 36.58M 33.90M 32.79M 24.32M
Weighted Average Shares Outstanding (Diluted)
37.20M 36.58M 33.90M 32.79M 24.32M
Currency in CHF

Kuros Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis